Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

ELAN

Elanco Animal Health Inc

Pharmaceutical Preparations · SIC 2834CIK 1739104Held by 7 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$4.72B
Net Income FY2025
$(0.23B)
EPS (Basic, as reported)
$-0.47
Net Margin FY2025
-4.9%
ROE FY2025
-3.5%
Total Equity
$6.55B
Shares Out
500M
Business description

Elanco Animal Health Inc — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2016–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 2,914 → 4,715 +5.5% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue2,9142,8893,0673,0713,2734,7654,4114,4174,4394,715
Cost of revenue(1,409)(1,494)(1,574)(1,470)(1,667)(2,134)(1,913)(1,931)(2,003)(2,122)
Gross profit———————2,4862,4362,593
Research & development(266)(252)(247)(270)(327)(369)(321)(327)(344)(368)
Selling, general & administrative(785)(780)(735)(760)(997)(1,404)(1,265)(1,285)(1,314)(1,430)
Total operating expenses(2,936)(3,122)(2,953)(2,993)(3,945)(5,332)(4,483)(5,612)(3,951)—
Interest expense00(30)(79)(150)(236)(241)(277)(235)(220)
Interest & investment income———————43143
Other income (expense), net30(41)(27)178(5)(32)(75)——
Pre-tax income(22)(233)11478(672)(567)(72)(1,195)488(224)
Income tax expense(25)(78)(28)(10)(112)(95)(6)(36)(150)(8)
Net income(48)(311)8768(560)(472)(78)(1,231)338(232)
EPS — basic—($1.06)$0.28$0.18($1.27)($0.97)($0.16)($2.50)$0.68($0.47)
EPS — diluted—($1.06)$0.28$0.18($1.27)($0.97)($0.16)($2.50)$0.68($0.47)
Shares outstanding — basic (M)293293314369441487488492494496
Shares outstanding — diluted (M)—293314370441487488492497496

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.